SAHAR GHORANY: Open Payments
NPI 1720620883 · FULLERTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$519 in 7 payments from 4 companies in 2025. Trend: 2023 $73 · 2024 $90 · 2025 $519
Food & beverage: $519
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $293 |
| ABBVIE INC. | 1 | $135 |
| Janssen Biotech, Inc. | 2 | $56 |
| UCB, Inc. | 1 | $35 |
Products named: DUPIXENT, BOTOX, TREMFYA, Bimzelx.
Industry payments across CA — which companies pay providers there.
